Abstract:This real-world study aimed to characterize the impact of illness of excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea (OSA) who are adherent to continuous positive airway pressure (CPAP). This cross-sectional study surveyed participants in Evidation Health's Achievement app (November 2020–January 2021), a mobile consumer platform that encourages users to develop healthy habits and provides incentives to participate in research. Participants were US-resident adults who self-reported a physician diagnosis of OSA and adherence to CPAP (≥4 hours/night, ≥5 nights/week) for≥6 months. The survey included the Functional Outcomes of Sleep Questionnaire-Short Version (FOSQ-10), Epworth Sleepiness Scale (ESS), and questions regarding comorbidities, CPAP use, caffeine consumption, and physical activity. EDS was defined as ESS score >10. There were more female than male participants; therefore, data were reported separately for females/males. In total, 476 participants (female, n = 283 [59%]; mean [SD] age, 49.7 [10.8] years; obese, 74.4%) completed the survey; 209 had EDS (mean [SD] ESS, 13.8 [2.5]) and 267 did not (mean [SD] ESS, 6.3 [2.5]). Self-reported duration of CPAP use was consistent between the EDS/no EDS cohorts, with most participants using CPAP for 7 to 9 hours/night, 7 nights/week. Participants with EDS commonly reported anxiety ([EDS/no EDS] males: 31.5%/20.0%; females: 53.7%/39.5%), depression (males: 35.6%/24.2%; females: 55.9%/44.9%), and insomnia (males: 19.2%/6.7%; females: 25.7%/12.9%) and showed impairment on the FOSQ-10 ([EDS/no EDS] males: 80.8%/35.0%; females: 91.9%/53.1%). Participants with EDS reported that sleepiness ' very often' prevented physical activity and influenced dietary choices. EDS influences choices related to physical activity, caffeine consumption, and diet in patients who are adherent with CPAP. More research is needed to understand the association between EDS and choices of CPAP-adherent patients. Future research should explore the health-related consequences of residual EDS associated with OSA and whether they can be mitigated by improving EDS. Approximately 1 billion people worldwide have a sleep disorder called obstructive sleep apnea (OSA). People with OSA experience a blockage in their upper airway during sleep, which can lead to snoring, gasping for air, difficulty breathing, and disturbed sleep. As a result, 50%–80% of people with OSA experience excessive daytime sleepiness (EDS) – the irresistible need to sleep during the daytime. Many people (9%–22%) who are treated for OSA using continuous positive airway pressure (CPAP) still experience EDS. Previous studies have described the negative impact EDS has on people, such as decreased work productivity and increased risk of motor vehicle accidents. However, it is unclear if EDS impacts health, behavioral choices, and lifestyle in the real world. This study surveyed people with OSA and collected their Fitbit data using Evidation's Achievement app. People with OSA and EDS reported having anxiety, depression, insomnia, and other health problems more often than people with OSA without EDS. Also, people with OSA and EDS reported having more impairments in daytime functioning than people with OSA without EDS. Furthermore, people with OSA and EDS reported that sleepiness 'very often' prevented them from engaging in physical activity. Women with OSA and EDS said that sleepiness 'very often' influenced their food choices. People with OSA and EDS also used caffeine and 'sometimes' used physical activity to stay awake during the daytime. Findings from this study show people with OSA alter their lifestyle and behavioral choices because of EDS.

Predictors of the Efficacy for Daytime Sleepiness in Patients with Obstructive Sleep Apnea with Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials.

[Effects of Continuous Positive Airway Pressure on Daytime Sleepiness in Patients with Severe Obstructive Sleep Apnea Syndrome].

Ventilatory Burden Predicts Change in Sleepiness Following Positive Airway Pressure in Sleep Apnea

Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: A comprehensive network meta-analysis and systematic review

0571 Impact of CPAP Adherence on Objective and Subjective Sleepiness Measures

Associations Between Objective Sleepiness and Cognition Function Before and after CPAP in Obstructive Sleep Apnea Patients

Meta-analysis of continuous positive airway pressure for obstructive sleep apnea syndrome patients in subjective outcomes of sleepiness behavior and mood status

The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea

Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management

A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea

Effect of CPAP vs. mandibular advancement device for excessive daytime sleepiness, fatigue, mood, sustained attention, and quality of life in patients with mild OSA

Factors associated with excessive daytime sleepiness in patients with severe obstructive sleep apnea

0672 Sleepiness, Psychomotor Vigilance and Cognition in People with OSA Adherent to PAP Therapy

Cognitive Effects of Treating Obstructive Sleep Apnea: A Meta-Analysis of Randomized Controlled Trials

Correlation of Epworth Sleepiness Scale with Multiple Sleep Latency Test and Its Diagnostic Accuracy in Assessing Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

[Effect of Objective Daytime Sleepiness on Heart Rate Variability in Patients With Obstructive Sleep Apnea].

0560 CPAP Effect on Energy Expenditure, Intake, Body Composition, and Sleep Patterns: A Randomized Controlled Trial

CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function

Health-related impact of illness associated with excessive daytime sleepiness in patients with obstructive sleep apnea

Optimal treatment of obstructive sleep apnea and excessive sleepiness

Phenotyping patients treated for obstructive sleep apnea with persistent objective impaired alertness or subjective sleepiness